i was on that prr ride too to 20c.
but to me the difference between ADO and PRR or many other bio companies is
- ADO can have many positive news coming in (ie. deals after deals) in a short period of time
it is already mentioned in recent presentation
1. Currently 2-3 healthcare R&D companies actively considering Mix&Go? - short term revenue opportunities as R&D companies take less time on approval processes
2. ADO is currently working on supply agreements with leading global IVD players
from the above i do see at least 4 deals being ironed out this year.
my chartist friends, page-2
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
-0.002(8.33%) |
Mkt cap ! $54.31M | |||
| Open | High | Low | Value | Volume |
| 2.4¢ | 2.4¢ | 2.2¢ | $40.20K | 1.786M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 386453 | 2.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.3¢ | 248196 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| ADO (ASX) Chart |